Thousands of individuals may require intricate surgery to eliminate risky spinal implants. Patients with degenerated neck discs were given M6-C artificial implants as a safer option to spinal fusion with metal rods. However, the implant has been associated with osteolysis, a condition where the body destroys and reabsorbs bone tissue.
Penningtons Manches Cooper law firm has been contacted by at least 10 individuals experiencing complications, including Sophia Harrison, 52, who had the implant inserted in 2019. She developed symptoms like pins and needles and a throat lump, later diagnosed as osteolysis. Sophia emphasized the need for awareness and prompt scans for implant recipients to prevent similar issues.
Australian authorities issued a bone loss hazard alert for the M6-C disc in 2020, but UK patients were not informed by the Medicines and Healthcare products Regulatory Agency (MHRA) until six years later. Sophia criticized the delayed disclosure, expressing frustration over facing complex surgeries due to bone disintegration.
Sophia’s solicitor, Lyndsey Skibinski, highlighted the potential public health impact, urging implant recipients to undergo scans and regular monitoring. Many may require surgery to remove the implants, posing risks of paralysis or chronic pain. Legal actions are being explored to seek justice for affected individuals and secure funding for future treatment.
Dr. Stephanie Millican of the MHRA acknowledged a delay in communicating osteolysis risks to UK users by the manufacturer. The agency emphasized patient safety, advising healthcare professionals to inform M6-C implant recipients about the risks, conduct routine monitoring, and consider further investigations and follow-ups. Reporting suspected side effects to the MHRA via the Yellow Card scheme is encouraged.